OBJECTIVE: To describe characteristics of the full population of women who participated in the Zika Contraception Access Network program in Puerto Rico during the virus outbreak and to examine factors associated with removal of a long-acting reversible contraception (LARC) method by a Zika Contraception Access Network provider during the program's duration (May 2016-September 2017). METHODS: We conducted an observational cohort study. The Zika Contraception Access Network program was designed to increase access to contraception services in Puerto Rico for women who chose to prevent pregnancy during the Zika virus outbreak as a primary strategy to reduce adverse Zika virus-related pregnancy and birth outcomes. Among program participants, an observational cohort of women served by the Zika Contraception Access Network Program, we describe their demographic and program-specific characteristics, including contraceptive method mix before and after the program. We also report on LARC removals by Zika Contraception Access Network providers during the program. We examined factors associated with LARC removal using multivariable logistic regression. RESULTS: A total of 29,221 women received an initial Zika Contraception Access Network visit during the program. Ninety-six percent (27,985) of women received same-day provision of a contraceptive method and 70% (20,381) chose a LARC method. While the program was active, 719 (4%) women who chose a LARC at the initial visit had it removed. Women with a college degree or higher were more likely to have their LARC removed (adjusted prevalence ratio [aPR] 1.24); breastfeeding women (aPR 0.67) and those using a LARC method before Zika Contraception Access Network (aPR 0.55) were less likely to have their LARC removed. CONCLUSION: The Zika Contraception Access Network program was designed as a short-term response for rapid implementation of contraceptive services in a complex emergency setting in Puerto Rico and served more than 29,000 women. The Zika Contraception Access Network program had high LARC uptake and a low proportion of removals by a Zika Contraception Access Network provider during the program. A removal-inclusive design, with access to removals well beyond the program period, maximizes women's reproductive autonomy to access LARC removal when desired. This model could be replicated in other settings where the goal is to increase contraception access.
OBJECTIVE: To describe characteristics of the full population of women who participated in the Zika Contraception Access Network program in Puerto Rico during the virus outbreak and to examine factors associated with removal of a long-acting reversible contraception (LARC) method by a Zika Contraception Access Network provider during the program's duration (May 2016-September 2017). METHODS: We conducted an observational cohort study. The Zika Contraception Access Network program was designed to increase access to contraception services in Puerto Rico for women who chose to prevent pregnancy during the Zika virus outbreak as a primary strategy to reduce adverse Zika virus-related pregnancy and birth outcomes. Among program participants, an observational cohort of women served by the Zika Contraception Access Network Program, we describe their demographic and program-specific characteristics, including contraceptive method mix before and after the program. We also report on LARC removals by Zika Contraception Access Network providers during the program. We examined factors associated with LARC removal using multivariable logistic regression. RESULTS: A total of 29,221 women received an initial Zika Contraception Access Network visit during the program. Ninety-six percent (27,985) of women received same-day provision of a contraceptive method and 70% (20,381) chose a LARC method. While the program was active, 719 (4%) women who chose a LARC at the initial visit had it removed. Women with a college degree or higher were more likely to have their LARC removed (adjusted prevalence ratio [aPR] 1.24); breastfeeding women (aPR 0.67) and those using a LARC method before Zika Contraception Access Network (aPR 0.55) were less likely to have their LARC removed. CONCLUSION: The Zika Contraception Access Network program was designed as a short-term response for rapid implementation of contraceptive services in a complex emergency setting in Puerto Rico and served more than 29,000 women. The Zika Contraception Access Network program had high LARC uptake and a low proportion of removals by a Zika Contraception Access Network provider during the program. A removal-inclusive design, with access to removals well beyond the program period, maximizes women's reproductive autonomy to access LARC removal when desired. This model could be replicated in other settings where the goal is to increase contraception access.
Authors: Aline C Gubrium; Emily S Mann; Sonya Borrero; Christine Dehlendorf; Jessica Fields; Arline T Geronimus; Anu M Gómez; Lisa H Harris; Jenny A Higgins; Katrina Kimport; Kristin Luker; Zakiya Luna; Laura Mamo; Dorothy Roberts; Diana Romero; Gretchen Sisson Journal: Am J Public Health Date: 2015-11-12 Impact factor: 9.308
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Matthew Lozier; Laura Adams; Mitchelle Flores Febo; Jomil Torres-Aponte; Melissa Bello-Pagan; Kyle R Ryff; Jorge Munoz-Jordan; Myriam Garcia; Aidsa Rivera; Jennifer S Read; Stephen H Waterman; Tyler M Sharp; Brenda Rivera-Garcia Journal: MMWR Morb Mortal Wkly Rep Date: 2016-11-11 Impact factor: 17.586
Authors: Samantha M Olson; Augustina Delaney; Abbey M Jones; Christopher P Carr; Rebecca F Liberman; Nina E Forestieri; Van T Tong; Suzanne M Gilboa; Margaret A Honein; Cynthia A Moore; Janet D Cragan Journal: Birth Defects Res Date: 2019-07-02 Impact factor: 2.344
Authors: Kathryn M Curtis; Tara C Jatlaoui; Naomi K Tepper; Lauren B Zapata; Leah G Horton; Denise J Jamieson; Maura K Whiteman Journal: MMWR Recomm Rep Date: 2016-07-29
Authors: Naomi K Tepper; Howard I Goldberg; Manuel I Vargas Bernal; Brenda Rivera; Meghan T Frey; Claritsa Malave; Christina M Renquist; Nabal Jose Bracero; Kenneth L Dominguez; Ramon E Sanchez; Carrie K Shapiro-Mendoza; Blanca R Cuevas Rodriguez; Regina M Simeone; Nicki T Pesik; Wanda D Barfield; Jean Y Ko; Romeo R Galang; Janice Perez-Padilla; Kara N D Polen; Margaret A Honein; Sonja A Rasmussen; Denise J Jamieson Journal: MMWR Morb Mortal Wkly Rep Date: 2016-04-01 Impact factor: 17.586
Authors: Rui Li; Sascha R Ellington; Romeo R Galang; Scott D Grosse; Zipatly Mendoza; Stacey Hurst; Yari Vale; Eva Lathrop; Lisa Romero Journal: Contraception Date: 2021-11-05 Impact factor: 3.375
Authors: Lisa Romero; Rachel Powell; Charity Ntansah; Hailey Bednar; Caitlin Green; Anna Brittain; Ruben Torrez; Irene Barrineau; Heather S Pangelinan; Ianeta Timoteo-Liaina; Luis Garcia; Eva Lathrop Journal: Hawaii J Health Soc Welf Date: 2022-09
Authors: Chelsea B Polis; Ann Biddlecom; Susheela Singh; Boniface Ayanbekongshie Ushie; Lori Rosman; Abdulmumin Saad Journal: Sex Reprod Health Matters Date: 2022-12
Authors: Lisa Romero; Rosa M Corrada-Rivera; Xavier Huertas-Pagan; Francisco V Aquino-Serrano; Ana M Morales-Boscio; Marizaida Sanchez-Cesareo; Edna Acosta-Perez; Zipatly Mendoza; Eva Lathrop Journal: J Public Health Manag Pract Date: 2022 Mar-Apr 01
Authors: Rachel Powell; Jackie Rosenthal; Euna M August; Meghan Frey; Luis Garcia; Turquoise Sidibe; Zipatly Mendoza; Lisa Romero; Eva Lathrop Journal: Health Commun Date: 2020-10-04